OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
ACE inhibitor or ARB treatment among patients with diabetes and chronic kidney disease
Linda F. Fried, Natalia Petruski‐Ivleva, Kerstin Folkerts, et al.
The American Journal of Managed Care (2021) Vol. 27, Iss. Suppl 20, pp. S360-S368
Open Access | Times Cited: 8
Linda F. Fried, Natalia Petruski‐Ivleva, Kerstin Folkerts, et al.
The American Journal of Managed Care (2021) Vol. 27, Iss. Suppl 20, pp. S360-S368
Open Access | Times Cited: 8
Showing 8 citing articles:
Chronic Kidney Disease in the Older Adult Patient with Diabetes
Raja Ravender, Maria‐Eleni Roumelioti, Darren W. Schmidt, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 348-348
Open Access | Times Cited: 9
Raja Ravender, Maria‐Eleni Roumelioti, Darren W. Schmidt, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 348-348
Open Access | Times Cited: 9
Overcoming barriers to implementing new guideline-directed therapies for chronic kidney disease
Robert Nee, Christina M. Yuan, Andrew S. Narva, et al.
Nephrology Dialysis Transplantation (2022) Vol. 38, Iss. 3, pp. 532-541
Open Access | Times Cited: 32
Robert Nee, Christina M. Yuan, Andrew S. Narva, et al.
Nephrology Dialysis Transplantation (2022) Vol. 38, Iss. 3, pp. 532-541
Open Access | Times Cited: 32
Exploring disulfiram mechanisms in renal fibrosis: insights from biological data and computational approaches
Vishal S. Patil, Chandragouda R. Patil, Harun Patel, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Vishal S. Patil, Chandragouda R. Patil, Harun Patel, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Clinical Evaluation of Dapagliflozin in the Management of CKD: Focus on Patient Selection and Clinical Perspectives
Khaled Nashar, Patricia Khalil
International Journal of Nephrology and Renovascular Disease (2022) Vol. Volume 15, pp. 289-308
Open Access | Times Cited: 9
Khaled Nashar, Patricia Khalil
International Journal of Nephrology and Renovascular Disease (2022) Vol. Volume 15, pp. 289-308
Open Access | Times Cited: 9
Get reliable laboratory findings – how to recognize the deceptive effects of angiotensin-converting enzyme inhibitor therapy in the laboratory diagnostics of sarcoidosis?
Attila Ádám Szabó, E.E. Enyedi, István Tibor Altorjay, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2024) Vol. 62, Iss. 7, pp. 1393-1401
Open Access | Times Cited: 1
Attila Ádám Szabó, E.E. Enyedi, István Tibor Altorjay, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2024) Vol. 62, Iss. 7, pp. 1393-1401
Open Access | Times Cited: 1
Kidney and cardiovascular-protective benefits of combination drug therapies in chronic kidney disease associated with type 2 diabetes
Muhammad Shahzeb Khan, Janice P. Lea
BMC Nephrology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Muhammad Shahzeb Khan, Janice P. Lea
BMC Nephrology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Chronic Kidney Disease in the Elderly Patient with Diabetes
Raja Ravender, Maria‐Eleni Roumelioti, Darren W. Schmidt, et al.
(2023)
Open Access | Times Cited: 1
Raja Ravender, Maria‐Eleni Roumelioti, Darren W. Schmidt, et al.
(2023)
Open Access | Times Cited: 1
Highly pathogenic coronaviruses and the kidney
Fang Wang, Xiao‐guo Suo, Cong Wang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113807-113807
Open Access | Times Cited: 2
Fang Wang, Xiao‐guo Suo, Cong Wang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113807-113807
Open Access | Times Cited: 2
